(Finance) – The ordinary shareholders’ meeting of Alkemya company specialized in the evolution of the business model of large and medium-sized companies
companies, met today in a single call under the chairmanship of Alessandro Mattiacci and proceeded to revoke the Board of Directors in office.
The company communicates this by reporting that all the directors, with the exception of the President of the Board of Directors, Alessandro Mattiacci, and the Managing Director, Duccio Vitali, have resigned with effect from the moment immediately preceding the start of the meeting’s work (with the exception for the councilor Massimo Canturi who resigned with effect from 7 October 2024). Limited to the President of the Board of Directors only, the revocation for just cause was resolved.
The ordinary shareholders’ meeting appointed the new Board of Directorscomposed of nine members, for the three-year period ending with the ordinary shareholders’ meeting to be convened in 2027 for the approval of the financial statements for the year ended 31 December 2026.
The following were appointed: Barnaba Ravanne, Marco Valcamonica, Duccio Vitali, Alessandra Piersimoni, Lisa Vascellari Dal Fiol, Maria Gimigliano, Elvina Finzi, Gerardo Gabrielli (taken from list no. 1 presented by the shareholder Retex SpA – Benefit Company, owner of a stake equal to 57.692% of the Company’s share capital and voted by the majority of shareholders present at the Meeting) and Vincenzo Pompa (taken from list no. 2 presented by the shareholders Startip Srl, Alessandro Mattiacci, Lappentrop Srl, Riccardo Cesare Lorenzini, Qmat Srl, Algebris Investments (Ireland) Limited and FIL Investments International, collectively holding a stake equal to 24.404% of the Company’s share capital and voted by the minority of shareholders present in the Assembly).
The ordinary shareholders’ meeting also appointed Barnaba Ravanne as President of the Board of Directors.